UTI AMC has announced a significant board change with the resignation of a long-serving director. The asset management company informed stock exchanges about the departure of Mr. Flemming Madsen from his position as Non-Executive Nominee Director, marking the end of a nearly 16-year tenure with the organization.

Director Resignation Details

The company disclosed that Mr. Flemming Madsen (DIN: 02904543) tendered his resignation as Non-Executive Nominee Director with effect from December 31, 2025. His departure coincides with the end of his association with T. Rowe Price International Ltd on the same date.

Regulatory Compliance and Timeline

UTI AMC received Madsen's resignation letter on December 16, 2025, at 21:25 hours IST. The company promptly disclosed this information to comply with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation will be effective from the close of business hours on December 31, 2025.

Director's Farewell Message

In his resignation letter dated December 16, 2025, from Baltimore, Madsen expressed gratitude for his tenure with UTI AMC. He stated that it had been "a great privilege and joy" to serve on the board throughout nearly 16 years. The departing director acknowledged the tremendous growth experienced by both the firm and the Indian mutual fund industry during his tenure.

Madsen offered his best wishes to the broader UTI team, clients, and other stakeholders for continued growth in the years ahead. As a Non-Executive Nominee Director representing T. Rowe Price, he indicated that his board seat would be vacated as his association with T. Rowe Price ends on December 31, 2025.

Corporate Governance Impact

The resignation represents a notable change in UTI AMC's board composition, given Madsen's extended tenure and his role as a nominee director from T. Rowe Price International Ltd. At the time of his resignation, Madsen was not serving on any board committees, which may minimize the immediate operational impact of his departure.

The company has fulfilled all disclosure requirements under the SEBI Listing Regulations and made the information available on its website as per regulatory guidelines. This resignation follows standard corporate governance practices when nominee directors' associations with their nominating entities conclude.

UTI Asset Management Company Limited (UTI AMC) has significantly expanded its employee ownership program with a substantial share allotment under its Employee Stock Option Scheme (ESOS) 2007. The company's Nomination and Remuneration Committee approved the allotment of 1,09,140 equity shares on December 15, following the exercise of stock options by eligible employees.

Share Allotment Details

The latest allotment represents a notable increase from the company's previous ESOP exercises, demonstrating growing employee participation in the ownership program.

Impact on Share Capital Structure

The allotment has resulted in a significant increase in UTI AMC's issued and paid-up share capital, reflecting the company's commitment to employee ownership.

Regulatory Compliance and Share Rights

The allotment was disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI master circular dated November 11. The newly allotted equity shares will rank pari-passu in all respects with the existing equity shares, ensuring equal rights and privileges including voting rights and dividend entitlements.

Strategic Implications

This substantial ESOP allotment underscores UTI AMC's strategy to enhance employee engagement and align workforce interests with shareholder value creation. The increased employee ownership stake demonstrates the company's confidence in its long-term growth prospects and commitment to retaining talent in the competitive asset management industry. For existing shareholders, while there is dilution in ownership percentage, the enhanced employee alignment could drive improved operational performance and business outcomes.